Reaction
How AI agents might challenge biotech's barriers to entry
One post argues AI agents could help small teams challenge biotech incumbents' reliance on patents and regulation.
TLDR
A post argues AI agents could give aspiring biotech founders access to knowledge once limited to established labs. Its author predicts incumbents will defend their positions with patents, lawsuits and regulation rather than faster innovation, and says similar pressure could reach banking, insurance and other industries.
Combined views
507.6K
2 Sources, first seen ago